Completed
Feasibility of Crystal Methamphetamine Interventions Among Gay, Bisexual and Other Men Who Have Sex With Men in Canada
Learn MoreCompleted
Development of a psychosocial intervention trial with the goal to improve older adults' ability to cope with HIV-Associated Neurocognitive Disorder (HAND)
Learn MoreReporting
Safety, tolerability, and effect on immune function of cannabinoids
Learn MoreCompleted
The effect of metformin on HIV reservoir size in non-diabetic ART-treated patients
Learn MoreCompleted
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
Learn MoreReporting
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Learn MoreReporting
Use of non-invasive methods for diagnosis of non-alcoholic steatohepatitis (NASH) in HIV patients and therapeutic use of vitamin E
Learn MoreCompleted
Rifabutin Therapy for the Prevention of MAC in Patients with AIDS
Learn MoreReporting
A pilot study of a novel, mRNA-based assay for the diagnosis of anal HPV infection HIV-positive MSM
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
